Proton Pharma Private Limited, a active private limited company, was established on 22 May 2012 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232CH2012PTC033816. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.10 M and a paid-up capital of ₹1.10 M.
It upholds a compliant status. Its leadership includes Sumit Tandon (Whole-Time Director), Ashwani Bhalla (Director). Past directors included Ved Prakash Aggarwal, Vijay Kumar Awasthi, Arvind Kumar. It holds no open charges and ₹1.98 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 165 Sector 38-C, Chandigarh, Chandigarh, 160038.
U24232CH2012PTC033816
033816
22 May 2012
₹1.10 M
₹1.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Proton Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Tandon | Whole-Time Director | 18 Nov 2015 | Current |
| Ashwani Bhalla | Director | 22 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Feb 2017 | Past |
| Pramod Abcsdd | Whole-Time Director | 18 Nov 2015 | Past |
| Pramod Abcsdd | Director | 15 Feb 2016 | Past |
| Pramod Abcsdd | Director | 18 Jul 2025 | Past |
| Pramod Abcsdd | Whole-Time Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Director | 20 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Proton Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 89.92% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Proton Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹19,778,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2013 | Axis Bank Limited | ₹1.98 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Proton Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Proton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proton Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Proton Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Proton Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
The activity A charge registered on 10 Dec 2013 via Charge ID 10467370 with Axis Bank Limited was fully satisfied on 02 Feb 2021. was completed.
Progress on Sumit Tandon was appointed as a Whole-time director was appointed as a Whole-time director on 18 Nov 2015 & has been associated with this company since 10 years 12 days . was documented.
Progress on A charge with Axis Bank Limited amounted to Rs. 19.78 M with Charge ID 10467370 was registered on 10 Dec 2013. was documented.
Ashwani Bhalla was appointed as a Director was appointed as a Director on 22 May 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.
The CIN of Proton Pharma Private Limited is U24232CH2012PTC033816.
Proton Pharma Private Limited is headquartered at Sco 165 Sector 38-C, Chandigarh, Chandigarh, 160038.
Proton Pharma Private Limited was incorporated on 22 May 2012.
The current directors of Proton Pharma Private Limited are
The primary industry of Proton Pharma Private Limited is Trade.
Proton Pharma Private Limited is unlisted.
The authorized capital of Proton Pharma Private Limited is ₹1.10 M, and the paid-up capital is ₹1.10 M.
The compliance status of Proton Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX